Smith, Salley & Associates Merck & Co., Inc. Transaction History
Smith, Salley & Associates
- $1.25 Billion
- Q1 2024
A detailed history of Smith, Salley & Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Smith, Salley & Associates holds 156,227 shares of MRK stock, worth $19.3 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
156,227
Previous 207,975
24.88%
Holding current value
$19.3 Million
Previous $22.7 Million
9.08%
% of portfolio
1.65%
Previous 1.51%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,766Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$25.6 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.5 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.7 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$6.98 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $314B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...